Disclosures for "Real-world Evidence of Longevity of BoNT/A in Cervical Dystonia (RELY‑CD) - Long‑term Dose–effect Outcomes with Complex‑free vs Complex‑containing Botulinum Toxin Type A"
-
Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
-
Mr. Waeschle has received personal compensation for serving as an employee of Merz Therapeutics GmbH.
-
Prof. Lee has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Tyslerowicz has nothing to disclose.
-
Dr. Sanchez Valiente has nothing to disclose.
-
Eva Lopez Valdes has nothing to disclose.
-
Georg Comes has received personal compensation for serving as an employee of Merz Therapeutics GmbH.
-
Prof. Stark has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Prof. Stark has received intellectual property interests from a discovery or technology relating to health care.